These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12092246)

  • 1. [Magnetic carrier method- an expectation for antitumoral therapy].
    Iacob G; Ciochină AD; Bredeţean O
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):815-21. PubMed ID: 12092246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic drug targeting--biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment.
    Alexiou C; Jurgons R; Schmid RJ; Bergemann C; Henke J; Erhardt W; Huenges E; Parak F
    J Drug Target; 2003 Apr; 11(3):139-49. PubMed ID: 13129824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locoregional cancer treatment with magnetic drug targeting.
    Alexiou C; Arnold W; Klein RJ; Parak FG; Hulin P; Bergemann C; Erhardt W; Wagenpfeil S; Lübbe AS
    Cancer Res; 2000 Dec; 60(23):6641-8. PubMed ID: 11118047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic nanoparticles: prospects in cancer imaging and therapy.
    Tang M; Russell PJ; Khatri A
    Discov Med; 2007 Jun; 7(38):68-74. PubMed ID: 18093468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical applications of magnetic drug targeting.
    Lübbe AS; Alexiou C; Bergemann C
    J Surg Res; 2001 Feb; 95(2):200-6. PubMed ID: 11162046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization and distribution of magnetic chemotherapeutic drugs with magnetic targeting in rat brain.
    Li AM; Zhang CX; Fu XP; Zhang ZW; Xue QH; Yan RM; Yi LH
    Chin Med J (Engl); 2005 May; 118(10):824-7. PubMed ID: 15989762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetizable needles and wires--modeling an efficient way to target magnetic microspheres in vivo.
    Iacob G; Rotariu O; Strachan NJ; Häfeli UO
    Biorheology; 2004; 41(5):599-612. PubMed ID: 15477667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of nanocarrier systems in cancer nanotherapy.
    Mozafari MR; Pardakhty A; Azarmi S; Jazayeri JA; Nokhodchi A; Omri A
    J Liposome Res; 2009; 19(4):310-21. PubMed ID: 19863166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visualisation of tumour regression after local chemotherapy with magnetic nanoparticles - a pilot study.
    Lyer S; Tietze R; Jurgons R; Struffert T; Engelhorn T; Schreiber E; Dörfler A; Alexiou C
    Anticancer Res; 2010 May; 30(5):1553-7. PubMed ID: 20592340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic drug targeting in a permeable microvessel.
    Shaw S; Murthy PV; Sibanda P
    Microvasc Res; 2013 Jan; 85():77-85. PubMed ID: 23142713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted transarterial therapy of Vx-2 rabbit liver tumor with Yttrium-90 labeled ferromagnetic particles using an external magnetic field.
    Kobeiter H; Georgiades CS; Leakakos T; Torbenson M; Hong K; Geschwind JF
    Anticancer Res; 2007; 27(2):755-60. PubMed ID: 17465199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bi-modal approach against cancer: magnetic alginate nanoparticles for combined chemotherapy and hyperthermia.
    Ciofani G; Riggio C; Raffa V; Menciassi A; Cuschieri A
    Med Hypotheses; 2009 Jul; 73(1):80-2. PubMed ID: 19272717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug-carrier complex in targeted cancer chemotherapy].
    Kato T; Sato K
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1031-7. PubMed ID: 3291765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravesical administration of doxorubicin to swine bladder using magnetically targeted carriers.
    Leakakos T; Ji C; Lawson G; Peterson C; Goodwin S
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):445-50. PubMed ID: 12802508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel method of doxorubicin-SPION reversible association for magnetic drug targeting.
    Munnier E; Cohen-Jonathan S; Linassier C; Douziech-Eyrolles L; Marchais H; Soucé M; Hervé K; Dubois P; Chourpa I
    Int J Pharm; 2008 Nov; 363(1-2):170-6. PubMed ID: 18687392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-based targeted therapy for cancer tissue.
    Das M; Mohanty C; Sahoo SK
    Expert Opin Drug Deliv; 2009 Mar; 6(3):285-304. PubMed ID: 19327045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Indication for microcapsulated antineoplastic agents, with special reference to local therapy using magnetized powder].
    Karasawa N; Kato T; Saito T; Mori N; Nomoto H
    Nihon Ika Daigaku Zasshi; 1984 Aug; 51(4):516-9. PubMed ID: 6490808
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of novel magnetic nano-carriers for high-performance affinity purification.
    Nishio K; Masaike Y; Ikeda M; Narimatsu H; Gokon N; Tsubouchi S; Hatakeyama M; Sakamoto S; Hanyu N; Sandhu A; Kawaguchi H; Abe M; Handa H
    Colloids Surf B Biointerfaces; 2008 Jul; 64(2):162-9. PubMed ID: 18313904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads.
    Ojima I
    Acc Chem Res; 2008 Jan; 41(1):108-19. PubMed ID: 17663526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-frequency, magnetic-field-responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effect.
    Hayashi K; Ono K; Suzuki H; Sawada M; Moriya M; Sakamoto W; Yogo T
    ACS Appl Mater Interfaces; 2010 Jul; 2(7):1903-11. PubMed ID: 20568697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.